p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases K Zatloukal, C Stumptner, A Fuchsbichler, H Heid, M Schnoelzer, ... The American journal of pathology 160 (1), 255-263, 2002 | 722 | 2002 |
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins R Zenz, R Eferl, L Kenner, L Florin, L Hummerich, D Mehic, H Scheuch, ... Nature 437 (7057), 369-375, 2005 | 718 | 2005 |
Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer D Schramek, A Leibbrandt, V Sigl, L Kenner, JA Pospisilik, HJ Lee, ... Nature 468 (7320), 98-102, 2010 | 638 | 2010 |
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53 R Eferl, R Ricci, L Kenner, R Zenz, JP David, M Rath, EF Wagner Cell 112 (2), 181-192, 2003 | 619 | 2003 |
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy S Shalapour, J Font-Burgada, G Di Caro, Z Zhong, E Sanchez-Lopez, ... Nature 521 (7550), 94-98, 2015 | 534 | 2015 |
Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT–mTOR–S6K signaling and drug responses A Riedl, M Schlederer, K Pudelko, M Stadler, S Walter, D Unterleuthner, ... Journal of cell science 130 (1), 203-218, 2017 | 482 | 2017 |
Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases G Zollner, P Fickert, R Zenz, A Fuchsbichler, C Stumptner, L Kenner, ... Hepatology 33 (3), 633-646, 2001 | 467 | 2001 |
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway L Hui, L Bakiri, A Mairhorfer, N Schweifer, C Haslinger, L Kenner, ... Nature genetics 39 (6), 741-749, 2007 | 462 | 2007 |
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ... Cancer cell 27 (4), 516-532, 2015 | 445 | 2015 |
A dual role for autophagy in a murine model of lung cancer S Rao, L Tortola, T Perlot, G Wirnsberger, M Novatchkova, R Nitsch, ... Nature communications 5 (1), 3056, 2014 | 439 | 2014 |
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer Z Yao, S Fenoglio, DC Gao, M Camiolo, B Stiles, T Lindsted, ... Proceedings of the National Academy of Sciences 107 (35), 15535-15540, 2010 | 437 | 2010 |
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease R Zenz, R Eferl, C Scheinecker, K Redlich, J Smolen, HB Schonthaler, ... Arthritis research & therapy 10, 1-10, 2008 | 390 | 2008 |
A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis K Kollmann, G Heller, C Schneckenleithner, W Warsch, R Scheicher, ... Cancer cell 24 (2), 167-181, 2013 | 363 | 2013 |
c-Jun regulates eyelid closure and skin tumor development through EGFR signaling R Zenz, H Scheuch, P Martin, C Frank, R Eferl, L Kenner, M Sibilia, ... Developmental cell 4 (6), 879-889, 2003 | 333 | 2003 |
Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute murine colitis D Berry, C Schwab, G Milinovich, J Reichert, K Ben Mahfoudh, T Decker, ... The ISME journal 6 (11), 2091-2106, 2012 | 322 | 2012 |
Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man A Jais, E Einwallner, O Sharif, K Gossens, TTH Lu, SM Soyal, D Medgyesi, ... Cell 158 (1), 25-40, 2014 | 301 | 2014 |
Translational regulation mechanisms of AP-1 proteins PW Vesely, PB Staber, G Hoefler, L Kenner Mutation Research/Reviews in Mutation Research 682 (1), 7-12, 2009 | 290 | 2009 |
Stat5 tetramer formation is associated with leukemogenesis R Moriggl, V Sexl, L Kenner, C Duntsch, K Stangl, S Gingras, A Hoffmeyer, ... Cancer cell 7 (1), 87-99, 2005 | 280 | 2005 |
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects L Kenner, A Hoebertz, FT Beil, N Keon, F Karreth, R Eferl, H Scheuch, ... The Journal of cell biology 164 (4), 613-623, 2004 | 243 | 2004 |
The Fos‐related antigen Fra‐1 is an activator of bone matrix formation R Eferl, A Hoebertz, AF Schilling, M Rath, F Karreth, L Kenner, M Amling, ... The EMBO journal 23 (14), 2789-2799, 2004 | 238 | 2004 |